Search Results - colin+shea

2 Results Sort By:
SuBLIME: Automatic Brain Lesion Incidence and Detection Using Multimodality Longitudinal Magnetic Resonance Imaging
Subjects develop brain lesions over the natural course of a disease, Thus, there is a need to identify, estimate the size, and track the time course of new lesions as they are being formed and remain in the brain. Currently, this is done by a trained rteuroradiologist using sliceby- slice inspection, this process is very slow, can be prone to human...
Published: 3/13/2025   |   Inventor(s): Elizabeth Sweeney, Colin Shea, Russell Shinohara, Arthur Goldsmith, Daniel Reich, Ciprian Crainiceanu
Keywords(s): Brain Cancer, Cancers, CNS and Neurological Disorders, Disease Indication, Image Display Software, Image Processing Software, Imaging and Sensing Systems, Imaging Modality, In Vivo Medical Imaging, Magnetic Resonance Imaging (MRI)
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology, Technology Classifications > Computers, Electronics & Software, Technology Classifications > Medical Devices > Imaging, Technology Classifications > Medical Devices, Technology Classifications > Computers, Electronics & Software > Image Processing & Analysis, Clinical and Disease Specializations > Oncology > Brain Cancer
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025   |   Inventor(s): Li Lin
Keywords(s): Biologics, Cancers, Chemotherapy, Disease Indication, Nucleic Acid, Single, Skin Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Dermatology, Clinical and Disease Specializations > Oncology > Skin Cancer, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum